Scholar Rock (NASDAQ:SRRK) Stock Price Up 6.4%

Shares of Scholar Rock Holding Co. (NASDAQ:SRRKGet Free Report) rose 6.4% during mid-day trading on Friday . The stock traded as high as $10.13 and last traded at $9.99. Approximately 49,010 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 789,971 shares. The stock had previously closed at $9.39.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. Wedbush restated an “outperform” rating and set a $23.00 target price on shares of Scholar Rock in a research report on Tuesday, May 7th. HC Wainwright reissued a “buy” rating and issued a $30.00 target price on shares of Scholar Rock in a research note on Thursday, May 23rd. Piper Sandler restated an “overweight” rating and issued a $28.00 price objective on shares of Scholar Rock in a report on Tuesday, March 26th. Truist Financial reiterated a “buy” rating and set a $20.00 target price on shares of Scholar Rock in a report on Wednesday, April 3rd. Finally, Raymond James assumed coverage on shares of Scholar Rock in a report on Thursday, March 28th. They set a “strong-buy” rating and a $30.00 target price for the company. Five investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $25.17.

Check Out Our Latest Stock Analysis on Scholar Rock

Scholar Rock Price Performance

The company has a market capitalization of $748.85 million, a P/E ratio of -4.49 and a beta of 0.94. The firm’s fifty day moving average is $13.84 and its 200 day moving average is $15.09. The company has a debt-to-equity ratio of 0.24, a quick ratio of 6.58 and a current ratio of 6.58.

Scholar Rock (NASDAQ:SRRKGet Free Report) last issued its earnings results on Tuesday, May 7th. The company reported ($0.59) EPS for the quarter, missing analysts’ consensus estimates of ($0.48) by ($0.11). During the same period last year, the company posted ($0.46) EPS. As a group, analysts predict that Scholar Rock Holding Co. will post -2.4 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Scholar Rock

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Walleye Trading LLC purchased a new position in Scholar Rock in the first quarter valued at $178,000. Jane Street Group LLC boosted its holdings in Scholar Rock by 95.5% in the 1st quarter. Jane Street Group LLC now owns 244,318 shares of the company’s stock valued at $4,339,000 after purchasing an additional 119,363 shares during the last quarter. Kennedy Capital Management LLC acquired a new position in Scholar Rock in the 1st quarter valued at about $4,900,000. Bayesian Capital Management LP acquired a new position in Scholar Rock in the 1st quarter valued at about $258,000. Finally, Redmile Group LLC lifted its holdings in shares of Scholar Rock by 0.3% in the 1st quarter. Redmile Group LLC now owns 6,419,610 shares of the company’s stock worth $114,012,000 after acquiring an additional 17,105 shares during the last quarter. 91.08% of the stock is currently owned by institutional investors and hedge funds.

Scholar Rock Company Profile

(Get Free Report)

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.

Recommended Stories

Receive News & Ratings for Scholar Rock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scholar Rock and related companies with's FREE daily email newsletter.